N-Acetyl-L-Glutamate

DB04075InvestigationalSmall molecule

N-Acetyl-L-Glutamate is a glutamate derivate used to prevent allergic conjunctivitis. A drug used to prevent an eye inflammation caused by an allergic reaction.

Chemical structure of N-Acetyl-L-Glutamate
Formula / weight
C7H11NO5 · 189.1659 g/mol (avg)

Resolves to

Compound
UNIIMA61H539YZCAS1188-37-0ChEMBLCHEMBL1234751ChEBI17533PubChem70914KEGGC00624
Clinical / RWD
RxNorm2001205
Structure
InChIKeyRFMMMVDNIPUKGG-YFKPBYRVSA-NSMILESCC(=O)N[C@@H](CCC(O)=O)C(O)=O
Targets
P0A6C8argBQ9HTN2argB

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with N-Acetyl-L-Glutamate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In